Secukinumab Rapidly Improves Disease Severity in Mild to Moderate Psoriasis
Secukinumab treatment resulted in greater improvements compared with placebo at week 12, with responses increasing through week 52.
Source: hcplive.com
Brucee Strober News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Brucee Strober. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Brucee Strober Today - Breaking & Trending Today
Bruce E Strober, MD, PhD: Efficacy of Risankizumab for Treating Plaque Psoriasis
Results of several clinical trials demonstrated the superior efficacy of risankizumab compared with apremilast or placebo.
Source: hcplive.com
AMERICAN SKIN ASSOCIATION ANNOUNCES 2023 RESEARCH ACHIEVEMENT AWARDS
/PRNewswire/ -- American Skin Association (ASA) announced the recipients of the 2023 David Martin Carter Mentor Award, 2023 George W. Hambrick Award, and the...
Source: prnewswire.com
A Topical Treatment Revolution is on the Horizon for Psoriasis
Healio Psoriatic Disease | Topical steroids have remained a mainstay first-line treatment for psoriasis, but two new drugs in development aim to revolutionize how topical drugs are used in treatment of the disease.“We’ve had a decent amount of minor innovation in psoriasis,” Mark G. Lebwohl, MD, dean for clinical therapeutics and chair emeritus of the Kimberly and Eric J. Waldman Department of Dermatology
Source: healio.com